2C-B
Timeline
| 1974 | 2C-B is first synthesized by Alexander Shulgin during an exploration of the homologues of DOB. 1 | |
| 1975 | First publication on 2C-B, by Alexander Shulgin and Michael Carter. 2 | |
| Jun 25, 1975 | Psychoactivity of 2C-B first discovered by Alexander Shulgin. Described as 'beautifully active'. 1 | |
| Late 1980s | 2C-B is marketed as an MDMA (ecstasy) replacement and becomes somewhat more popular after MDMA is scheduled in 1985. | |
| 1991 | Alexander and Ann Shulgin publish PiHKAL, documenting over 250 phenethylamines, including MDMA, mescaline, 2C-B, 2C-T-7, 2C-T-2, and many others. 3 | |
| Jan 6, 1994 | 2C-B added to Schedule I through the emergency scheduling process, making it illegal to possess or sell in the United States. | |
| Jun 2, 1995 | 2C-B placed "permanently" into Schedule I in the United States. | |
| 1997 | 2C-B becomes illegal in the Netherlands | |
| Jun 1998 | 2C-B becomes illegal in Japan. |
References
- Shulgin AT. Personal communication.
- Shulgin AT, Carter MF. "Centrally Active Phenethylamines". Psychopharm Commun. 1975;1:93-98.
- Shulgin AT, Shulgin A. PiHKAL: A Chemical Love Story. Transform Press. 1991.